Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | DPP4 | P27487 | 2/20 | 0.35 |
| ▸ | CCNE1 | P24864 | 12/20 | 0.34 |
| ▸ | CDK2 | P24941 | 12/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | GSK3B | P49841 | 7/20 | 0.33 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2145078 | 1.00 | EPHX1 (0.37) | EPHX1DPP4CCNE1CDK2SMN1; SMN2 | |
| SCHEMBL2145085 | 1.00 | EPHX1 (0.37) | EPHX1DPP4CCNE1CDK2SMN1; SMN2 | |
| SCHEMBL25270786 | 0.93 | EPHX1 (0.40) | EPHX1DPP4CCNE1CDK2SMN1; SMN2 | |
| SCHEMBL27855976 | 0.91 | NAAA (0.35) | EPHX1DPP4CCNE1CDK2GSK3B | |
| SCHEMBL7815595 | 0.90 | EPHX1 (0.42) | EPHX1DPP4CCNE1CDK2SMN1; SMN2 | |
| SCHEMBL23437012 | 0.89 | EPHX1 (0.42) | EPHX1DPP4SMN1; SMN2APOBEC3AAPOBEC3G | |
| SCHEMBL25281021 | 0.89 | CCNE1 (0.37) | DPP4CCNE1CDK2GSK3B | |
| SCHEMBL25271862 | 0.89 | CCNE1 (0.37) | DPP4CCNE1CDK2GSK3B | |
| SCHEMBL27760444 | 0.89 | CCNE1 (0.37) | DPP4CCNE1CDK2GSK3B | |
| Methane SCHEMBL27968861 | 0.88 | EPHX1 (0.41) | EPHX1DPP4CCNE1CDK2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108727363-B | Novel cyclin dependent kinase CDK9 inhibitor | 劲方医药科技(上海)有限公司 | 2020-06-19 | — | — | CN | disclosed |
| EP-2470536-B1 | Methylpyrrolopyrimidinecarboxamides | TAKEDA GMBH (DE) | 2014-11-12 | — | — | EP | disclosed |